For information about Africhol's programs and activities, please contact:
Latest News, Outbreak Notifications:
Follow Africhol on Twitter
Hilleman Laboratories advances two vaccines into clinical stage
Hilleman Laboratories (27 Apr 2016)
...Hilleman Laboratories also obtained regulatory clearance for its innovative oral Cholera vaccine to conduct a Phase I/II clinical study that is intended to lead to an affordable vaccine against devastating Cholera infection.
How vibrio cholera is attracted by bile revealed
Phys.org (25 Apr 2016)
A group of researchers from Osaka University, Hosei University, and Nagoya University have revealed the molecular mechanism that Vibrio cholerae, the etiological agent of cholera, is attracted by bile.
Crab Shell Signaling Helps Control the Many Faces of Cholera, Study Shows
Georgia Institute of Technology (6 Apr 2016)
A new study of more than 50 samples of Vibrio cholerae isolated from both patients and the environment demonstrates the diversity and resourcefulness of the organism.
Single-dose live oral cholera vaccine safely reduces diarrhea
Healio (28 Mar 2016)
A single-dose live cholera vaccine taken orally appeared to reduce the incidence of diarrhea among adults with no increase in adverse events, according to a recently published study.